Welcome to LookChem.com Sign In|Join Free
  • or
Dregeoside Aa1, also known as "Dregeoside," is a natural chemical compound isolated from the roots of the medicinal plant Dregea volubilis. It belongs to the class of iridoids, which are known for their diverse biological activities. Dregeoside Aa1 has been found to possess significant anti-inflammatory, antioxidant, and antiproliferative properties, making it a promising candidate for the treatment of various diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. The scientific community has shown interest in Dregeoside Aa1 due to its potential therapeutic applications, and ongoing research is being conducted to explore its pharmacological properties and potential medical uses.

20230-41-5

Post Buying Request

20230-41-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20230-41-5 Usage

Uses

Used in Pharmaceutical Industry:
Dregeoside Aa1 is used as a therapeutic agent for its anti-inflammatory, antioxidant, and antiproliferative properties, making it a potential candidate for the treatment of various diseases such as cancer, neurodegenerative disorders, and inflammatory conditions.
Used in Cancer Treatment:
Dregeoside Aa1 is used as an anticancer agent, targeting the inhibition of tumor growth and progression. Its antiproliferative properties make it a promising compound for further research and development in oncology.
Used in Neurodegenerative Disorder Treatment:
Dregeoside Aa1 is used as a neuroprotective agent, leveraging its antioxidant properties to combat oxidative stress associated with neurodegenerative disorders, potentially slowing down or preventing the progression of these conditions.
Used in Inflammatory Condition Treatment:
Dregeoside Aa1 is used as an anti-inflammatory agent, helping to reduce inflammation and alleviate symptoms in various inflammatory conditions.
Used in Drug Delivery Systems:
To enhance the bioavailability and therapeutic outcomes of Dregeoside Aa1, novel drug delivery systems are being developed. These systems aim to improve the compound's delivery to target tissues, increasing its efficacy and reducing potential side effects.

Check Digit Verification of cas no

The CAS Registry Mumber 20230-41-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,2,3 and 0 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 20230-41:
(7*2)+(6*0)+(5*2)+(4*3)+(3*0)+(2*4)+(1*1)=45
45 % 10 = 5
So 20230-41-5 is a valid CAS Registry Number.

20230-41-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,3,6,8-Tetraazaspiro[4.4]nonane-2,4,7,9-tetrone

1.2 Other means of identification

Product number -
Other names D-prolyl-D-leucylglycylglycine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20230-41-5 SDS

20230-41-5Relevant academic research and scientific papers

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 20230-41-5